Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Alchymars ICM SM Private Limited
WARNING LETTER
•Alchymars ICM SM Private Limited•September 15, 2017

Alchymars ICM SM Private Limited – FDA Warning Letter, Sep 15, 2017

Record Details

The FDA issued a Warning Letter to Alchymars ICM SM Private Limited following a September 11-15, 2017, inspection of their Tamil Nadu, India, drug manufacturing facility, identifying significant CGMP deviations for active pharmaceutical ingredients (API), rendering their API adulterated.

Key violations include: 1. **Falsification of laboratory data:** Discrepancies in CFU counts for water point-of-use tests and observed growth on selective media despite reported absence, particularly concerning for API used in sterile injectable forms. 2. **Inadequate equipment maintenance:** Damaged product-contact surfaces (e.g., deteriorating gaskets) on multi-product equipment, with a lack of gasket replacement records, a repeat observation from a 2015 inspection. 3. **Insufficient quality unit investigations:** Failure to thoroughly investigate customer complaints regarding black spots and out-of-specification moisture content in API, without detailed record reviews. 4. **Poor facility maintenance:** Filthy equipment washroom with damaged tiles and standing water, and visibly dirty handwashing stations in cleanroom areas. 5. **Inadequate personnel facilities:** Inconveniently located and non-functional handwashing stations lacking hot water, soap, or hand drying equipment, also a repeat observation.

The FDA deemed the company's responses inadequate and strongly recommended engaging a qualified CGMP consultant to address systemic issues, particularly data integrity, laboratory controls, investigations, maintenance, and quality oversight

Company
Alchymars ICM SM Private Limited
Inspection date
September 15, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · bcc492fc-da9a-46d3-815b-2352c09879d1

Violation Codes5
21 U.S.C. 351(a)(2)(B)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)21 U.S.C. 356C(b)

Full citation text and observation details available on the Dashboard.

Other documents for Alchymars ICM SM Private Limited
  • 483 - 2025-12-04December 4, 2025
  • WARNING_LETTER - 2025-12-04December 4, 2025
  • 483 - 2025-11-28November 28, 2025
  • 483 - 2018-10-19October 19, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alchymars ICM SM Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.